1. Home
  2. FT vs ORMP Comparison

FT vs ORMP Comparison

Compare FT & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Universal Trust

FT

Franklin Universal Trust

HOLD

Current Price

$7.84

Market Cap

199.8M

Sector

Finance

ML Signal

HOLD

Logo Oramed Pharmaceuticals Inc.

ORMP

Oramed Pharmaceuticals Inc.

HOLD

Current Price

$4.29

Market Cap

170.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FT
ORMP
Founded
1988
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
199.8M
170.3M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
FT
ORMP
Price
$7.84
$4.29
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
34.3K
154.5K
Earning Date
01-01-0001
05-14-2026
Dividend Yield
7.85%
6.51%
EPS Growth
N/A
412.50
EPS
N/A
2.76
Revenue
N/A
$2,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$4.63
Revenue Growth
N/A
49.25
52 Week Low
$7.79
$1.98
52 Week High
$8.35
$5.19

Technical Indicators

Market Signals
Indicator
FT
ORMP
Relative Strength Index (RSI) 36.60 50.65
Support Level $7.84 $3.91
Resistance Level $8.08 $4.22
Average True Range (ATR) 0.06 0.19
MACD -0.01 0.01
Stochastic Oscillator 13.33 46.37

Price Performance

Historical Comparison
FT
ORMP

About FT Franklin Universal Trust

Franklin Universal Trust is a closed-end management investment company focused on providing high current income while preserving capital. Its secondary objective is to achieve income growth through dividend increases and capital appreciation. The fund invests in two asset classes: high-yield bonds and utility stocks. It applies fundamental research to build a diversified high-yield bond portfolio and targets utility companies with attractive dividend yields and a history of increasing dividends.

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.

Share on Social Networks: